Global Colon Cancer Association

Clinical trials should reflect the communities they serve. Join GCCA CEO @AndrewRSpiegel on July 23 for a @reutersevents webinar on improving trial representation through smarter site selection, community partnerships, and patient-centered recruitment strategies. 📅 July 23 🕚 11 AM EDT Register: gcca.info/Webinar_7_23_2… #ClinicalTrials #PatientAdvocacy #HealthEquity@

Webinar: HER2 and Colorectal Cancer, What Advocates Need to Know. With Dr. Strickler, advocate Elle Charnisky, and moderator @NicoleMSheahan . Thank you to @pfizer for supporting this educational program.

Meet our webinar speaker: Dr. John Strickler, Professor at Duke University and a leader in precision medicine for GI cancers. He led the trial behind the first FDA-approved therapy for HER2-positive metastatic colorectal cancer. Join us July 29, 11am EDT. Register: gcca.info/HER_2_X #ColorectalCancer #HER2

Health equity begins with trust. In rural Nigeria, the @Davido_menukor Foundation brought colorectal cancer education and screening directly into the community. 📊 2,500 people educated 📊 310 FIT kits distributed 📊 38 positive results identified for follow-up care Read the full story: gcca.info/Blog_Post_7_12… #ColorectalCancer #CRC #HealthEquity #GlobalHealth@

Please join us in welcoming our newest member, Footprints 2 Africa. Footprints 2 Africa is a UK-registered, 100% volunteer-led charity that collects surplus ostomy and medical supplies across the UK and redistributes them to under-resourced hospitals and vulnerable ostomates across Africa.

Their belief that no one should lose their life to cancer due to ignorance or lack of access is the kind of powerful statement that aligns with GCCA, and we are thrilled to have them as members!

Please join us in welcoming our newest member, Youth Unite Against Cancer Initiative (YUACI). Youth Unite Against Cancer Initiative is a youth-led organization committed to raising awareness, promoting early detection, and supporting individuals affected by cancer.

Offering vital navigation and emotional support to patients, survivors, and their families throughout their care journey is the kind of community support that changes lives. Learn more : cafafghana.org

Please join us in welcoming our newest member, Community and Family Aid Foundation (CAFAF).  The Community and Family Aid Foundation is dedicated to improving the health, well-being, and socio-economic conditions of vulnerable individuals, families, and underserved communities.

Bridging gaps between communities, clinicians, and care systems to drive more informed, equitable, and effective health outcomes is what patient advocacy is all about! Learn more about COGI here: colorofgi.org

Please welcome our newest member @colorofgi The Color of Gastrointestinal Illnesses. The Color of Gastrointestinal Illnesses (COGI) is a national nonprofit working to improve the quality of life for people disproportionately affected by digestive diseases and chronic illness through community building, research, education, and advocacy.

The new @WHO Global Status Report on Cancer calls for a more people-centered, equitable approach to cancer care. What does that mean for the colorectal cancer community? Read @NicoleMSheahan 's latest blog: gcca.info/Blog_Post_7_10… #ColorectalCancer #CancerAdvocacy #HealthEquity

Looking for clinical trials related to a specific biomarker? The Clinical Trial Finder on each KnowYourBiomarker.org biomarker page connects patients and healthcare professionals to biomarker-specific studies from ClinicalTrials.gov. 🧬 Explore relevant trials 🔍 Search by biomarker 🌍 Stay informed Visit gcca.info/CTA_widget_X #ClinicalTrials #PrecisionMedicine #Biomarkers #CRC

Join a conversation that brings together science and lived experience. John Strickler, MD helped lead the trial that resulted in the first FDA-approved HER2-targeted therapy for metastatic colorectal cancer. Elle Charnisky participated in that research and now advocates for patients living with CRC. Register now for our free HER2 webinar. gcca.info/HER_2_X #ColorectalCancer #HER2 #BiomarkerTesting

Join us for HER2 and Colorectal Cancer: What Advocates Need to Know, with Dr. John Strickler, advocate Elle Charnisky, and moderator Nicole Sheahan. Thank you to @pfizer for supporting this educational program.

Do you know HER2? You've heard of it in breast cancer. But it matters in colorectal cancer too, found in about 3 to 5% of cases. Knowing your status can open doors to more personalized treatment. Free webinar, July 29, 11am EDT. Register: gcca.info/HER_2_X #ColorectalCancer #HER2

📅 GCCA July Member Meeting —July 15 at 22:00 UTC. Topic: Clinical Trials. Speaker: Sharon Rivera Sanchez of Trials of Color @ColorTrials . #GCCA #ColorectalCancer

Nominations for the 2026 Global CRC Leadership Awards are open through July 15. Help us recognize the leaders driving global progress in CRC policy, equity, and care. Self-noms not accepted. Nominate here: gcca.info/Leadership_awa…

Plot twist: HER2 isn't just a breast cancer biomarker. It shows up in colorectal cancer too, and testing for it could mean more treatment options. Ask your care team if your tumor's been tested. More info: gcca.info/HER_2_X

Please join us in welcoming our newest member, @brazza_usa Brazza International Foundation. Brazza International Foundation's mission is to provide capacity building in the areas of Healthcare, Education, and Patient Advocacy support and awareness to assist underserved communities in Africa and other developing nations